52
Views
15
CrossRef citations to date
0
Altmetric
Research Article

In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres

, , , &
Pages 689-699 | Received 12 Mar 1996, Accepted 15 Apr 1996, Published online: 27 Sep 2008

References

  • Açikgöz M., Kaş H. S., Hascelik Z., Milli Ü., Hincal A. A. Chitosan microspheres of diclofenac sodium. II. In vitro and in vivo evaluation. Pharmazie 1995; H. 4: 275–278
  • Açikgöz M., Kaş H. S., Orman M., Hincal A. A. Chitosan microspheres of diclofenac sodium. I. Application of factorial design and evaluation of release kinetics. Journal of Microencapsulation 1996; 13: 141–160
  • Arica B., Cetemen M., Öner L., Kaş H. S., Hincal A. A. Microencapsulation of Diclofenac Sodium by Spray-Drying Process. Proceedings of the 9th International Symposium on Microencapsulation, H. S. Kaş, A. A. Hincal. Editions de Sante, Paris 1994; 136–141, (minutes)
  • Bain J. C., Tan S. B., Ganderton D., Solomon M. C. Comparison of the in vitro release characteristics of a wax matrix and a hydrogel sustained release diclofenac sodium tablet. Drug Development and Industrial Pharmacy 1991; 17(2)215–232
  • Bodmeier R., McGinity J. W. Solvent selection in the preparation of poly (DL-Lactide) microspheres prepared by the solvent evaporation method. International Journal of Pharmaceutics 1988; 13: 179–186
  • Calabro J. J. Efficiacy of diclofenac in Ankylosing Spondylitis. The American Journal of Medicine 1986; 80: 58–63, (Suppl. 4B)
  • Chemtob C., Chanmeil J. C., Dongo M. N. Microencapsulation by ethylcellulose phase separation: Microcapsules characteristics. International Journal of Pharmaceutics 1986; 29: 1–7
  • Darvari R., Hasirci V. Pesticide and model drug release from carboxymethyl-cellulose microspheres. Journal of Microencapsulation 1996, (in press)
  • Gohary O., Gamal S. Release of furosemide from sustained-release microcapsules prepared by phase separation technique. Drug Development and Industrial Pharmacy 1991; 17(3)443–450
  • Gross W., Kroh J., Krebs A., Zöller H. Diclofenac Sodium: Blood concentration of the slow-release form and influence on the metabolism of Kallikrein. Arzneim-Forsch./Drug Research 1984; 34(11)1327–1329
  • Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drug dispersed in solid matrices. Journal of Pharmaceutical Sciences 1963; 52: 1145–1149
  • Iannucelli V., Forni F., Vandelli M. A., Bernabei M. T. Effect of loading method on the drug release from crosslinked carboxymethylcellulose beads. Journal of Controlled Release 1993; 23: 13–20
  • Lin S. Y., Kao Y. H. Tablet formulation design of spray-dried sodium diclofenac enteric-coated microcapsules. Proceedings International Symposium Controlled Release Bioactive Materials. Controlled Release Society Inc., 1991; 18: 155–156
  • Martindale. The Extra Pharmacopoeia, 29th Ed. 1989; 12–13, 1989
  • Menasse R., Hedwell P. R., Kraetz J., Pericin C., Riesterer L., Sallmann A., Ziel R., Jaques R. Pharmacological properties of diclofenac sodium and its metabolites. Scandinavian Journal of Rheumatology 1978; Suppl 22: 5–16
  • Nishihata T. Simple formulation of sustained-release tablets of sodium diclofenac and examination in humans. International Journal of Pharmaceutics 1987; 40: 125–128
  • Riess W., Stierlin H., Degen P., Faigle J. W., Gerardin A., Moppert J., Sallmann A., Schmid K., Schweizer A., Sulc M., Theobald W., Wagner J. Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scandinavian Journal of Rheumatology 1978; 22: 17–29
  • Sato T., Schroder H. G., DeLuca P. P. Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. Pharmaceutical Research 1988; 5: 21–29
  • Schubiger B. I., Ciccolunghi S. N., Tanner K. Once daily dose treatment with a non-steroidal anti-rheumatic drug (diclofenac) in osteoarthrosis. Journal of International Medical Research 1980; 8: 167–174
  • Willkens R. F. Worldwide clinical safety experience with diclofenac. Seminars in Arthritis and Rheumatism 1985; 15: 105–110, (Suppl 1)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.